Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Resources
Our Tools
Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Contact

Search for:

∕
Knowledge Base
∕
Interventions

Topic: Interventions

Knowledge Base (Clinicians)

11 result(s) found.

Risperdal Consta/Risperidone for Extended-Release Injectable Suspension
What should clinicians know about Abilify Maintena (aripiprazole monohydrate LAI)?
What should clinicians know about Aristada (aripiprazole lauroxil LAI)?
What should clinicians know about haloperidol decanoate (“Haldol Dec”)?
What should clinicians know about fluphenazine decanoate (“Prolixin Dec”)?
What should clinicians know about Invega Trinza (paliperidone palmitate 12-week LAI)?
What should clinicians know about Invega Sustenna (paliperidone palmitate LAI)?
What should clinicians know about Zyprexa Relprevv (olanzapine for extended release injectable suspension)?
What should clinicians know about Invega Hafyera (paliperidone palmitate 6-month LAI)?
What should clinicians know about Uzedy (risperidone subcutaneous LAI)?
What should clinicians know about Abilify Asimtufii (aripiprazole LAI)?

Administered by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.